Lineage Cell Therapeutics Inc LCTX:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
1.20UNCH (UNCH)
Volume
14,601
Close
1.20quote price arrow down-0.09 (-6.98%)
Volume
1,025,295
52 week range
0.84 - 1.61
Loading...
  • Open1.30
  • Day High1.30
  • Day Low1.18
  • Prev Close1.29
  • 52 Week High1.61
  • 52 Week High Date03/28/24
  • 52 Week Low0.84
  • 52 Week Low Date02/01/24

Key Stats

  • Market Cap226.24M
  • Shares Out188.53M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change10.09

KEY STATS

  • Open1.30
  • Day High1.30
  • Day Low1.18
  • Prev Close1.29
  • 52 Week High1.61
  • 52 Week High Date03/28/24
  • 52 Week Low0.84
  • 52 Week Low Date02/01/24
  • Market Cap226.24M
  • Shares Out188.53M
  • 10 Day Average Volume1.10M
  • Dividend-
  • Dividend Yield-
  • Beta1.35
  • YTD % Change10.09

RATIOS/PROFITABILITY

  • EPS (TTM)-0.12
  • P/E (TTM)-9.65
  • Fwd P/E (NTM)-10.26
  • EBITDA (TTM)-24.041M
  • ROE (TTM)-31.42%
  • Revenue (TTM)8.945M
  • Gross Margin (TTM)92.50%
  • Net Margin (TTM)-240.12%
  • Debt To Equity (MRQ)0.23%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Lineage Cell Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs. The Company’s programs are based on its cell-based technology platform and associated development and manufacturing capabilities. From this platform, the Company designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions. Its neuroscience focused pipeline includes OpRegen, a retinal pigment...
Alfred Kingsley J.D.
Non-Executive Independent Chairman of the Board
Brian Culley
Chief Executive Officer, Director
Jill Howe
Chief Financial Officer
George Samuel III
General Counsel, Corporate Secretary
Address
2173 Salk Ave Ste 200
Carlsbad, CA
92008-7354
United States

Top Peers

SYMBOLLASTCHG%CHG
GBIO
Generation Bio Co
2.78-0.20-6.71%
IPSC
Century Therapeutics Inc
2.98+0.14+4.75%
QSI
Quantum-Si Inc
1.51-0.02-1.31%
GALT
Galectin Therapeutics Inc
3.38UNCHUNCH
CRDF
Cardiff Oncology Inc
4.37-0.13-2.89%